Plasma Levels of Tumor Necrosis Factor-α, Angiotensin II, Growth Hormone, and IGF-I Are Not Elevated in Insulin-Resistant Obese Individuals With Impaired Glucose Tolerance
Open Access
- 1 February 2001
- journal article
- Published by American Diabetes Association in Diabetes Care
- Vol. 24 (2), 328-334
- https://doi.org/10.2337/diacare.24.2.328
Abstract
OBJECTIVE— To investigate the relationship between insulin resistance and plasma concentrations of free fatty acids (FFAs), leptin, and potential agonists of the insulin receptor substrate (IRS) system, including tumor necrosis factor-α (TNF-α), IGF-I, growth hormone (GH), and angiotensin II in individuals with impaired glucose tolerance (IGT). RESEARCH DESIGN AND METHODS— Because glucose toxicity per se leads to insulin resistance, the determination of the primary metabolic alterations leading to insulin resistance is best accomplished in individuals who are at an increased risk to develop type 2 diabetes. Therefore, 48 subjects with IGT and insulin resistance (IR), characterized by hyperinsulinemic-euglycemic clamps, were compared with 52 healthy insulin-sensitive (IS) control subjects with respect to the relationship between the plasma levels of TNF-α, IGF-I, GH, angiotensin II, FFA,leptin, and insulin resistance. RESULTS— Between the IR and the IS groups, there were no significant differences in the plasma concentrations of TNF-α, GH,angiotensin II, IGF-I, and leptin. However, plasma FFA levels were significantly elevated in the IR group compared with the IS group after matching for BMI. CONCLUSIONS— The plasma concentrations of FFA, but not TNF-α, IGF-I, GH, and angiotensin II, are elevated in patients at an early stage of insulin resistance, suggesting that FFAs, but not the other modulators of the IRS system, may be a primary metabolic abnormality leading to insulin resistance.Keywords
This publication has 50 references indexed in Scilit:
- The natural history of insulin secretory dysfunction and insulin resistance in the pathogenesis of type 2 diabetes mellitusJCI Insight, 1999
- Insulin Action and Secretion in healthy, glucose tolerant first degree relatives of patients with type 2 diabetes mellitus. Influence of body weightExperimental and Clinical Endocrinology & Diabetes, 1999
- Syndromes of Severe Insulin ResistanceJournal of Clinical Endocrinology & Metabolism, 1998
- Tissue availability of insulin-like growth factor I is inversely related to insulin resistance in essential hypertensionJournal Of Hypertension, 1998
- Decreased Insulin Sensitivity and Compensatory Hyperinsulinemia after Hormone Treatment in Children with Short StatureJournal of Clinical Endocrinology & Metabolism, 1997
- Altered action of angiotensin II in patients with type 2 diabetes mellitus of recent onsetJournal Of Hypertension, 1997
- Increased adipose tissue expression of tumor necrosis factor-alpha in human obesity and insulin resistance.JCI Insight, 1995
- Reduced tyrosine kinase activity of the insulin receptor in obesity-diabetes. Central role of tumor necrosis factor-alpha.JCI Insight, 1994
- Mechanisms of fatty acid-induced inhibition of glucose uptake.JCI Insight, 1994
- Measurement of Insulin-Like Growth Factor I (IGF-I) in Normal Adults, Patients with Liver Cirrhosis and Acromegaly: Experience with a New Competitive Enzyme ImmunoassayExperimental and Clinical Endocrinology & Diabetes, 1993